Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018

Cardiac Markers Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2018


  • Products Id :- GDME0655EPD
  • |
  • Pages: 126
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Cardiac Markers Rapid Tests & Point of Care (POC)-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Cardiac Markers Rapid Tests & Point of Care (POC)-Medical Devices Pipeline Assessment, 2018" provides an overview of Cardiac Markers Rapid Tests & Point of Care (POC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Markers Rapid Tests & Point of Care (POC) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiac Markers Rapid Tests & Point of Care (POC) under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Cardiac Markers Rapid Tests & Point of Care (POC) and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Cardiac Markers Rapid Tests & Point of Care (POC) under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 8

2 Introduction 9

2.1 Cardiac Markers Rapid Tests & Point of Care (POC) Overview 9

3 Products under Development 10

3.1 Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Stage of Development 10

3.2 Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Segment 11

3.3 Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Territory 12

3.4 Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Regulatory Path 13

3.5 Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Estimated Approval Date 14

4 Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products under Development by Companies 15

4.1 Cardiac Markers Rapid Tests & POC Companies-Pipeline Products by Stage of Development 15

4.2 Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Stage of Development 18

5 Cardiac Markers Rapid Tests & Point of Care (POC) Companies and Product Overview 21

5.1 1Drop Diagnostics Company Overview 21

5.2 Abionic SA Company Overview 22

5.3 Accel Diagnostics LLC Company Overview 23

5.4 Akers Biosciences Inc Company Overview 24

5.5 Akrivis Technologies LLC Company Overview 25

5.6 Alfa Wassermann Inc Company Overview 26

5.7 Anteo Diagnostics Ltd Company Overview 28

5.8 Atonomics A/S Company Overview 30

5.9 Axela Inc Company Overview 32

5.10 Axis-Shield Diagnostics Ltd Company Overview 33

5.11 BBB Technologies Inc Company Overview 34

5.12 Bio-Alternative Medical Devices Ltd Company Overview 35

5.13 BioMedomics Inc Company Overview 38

5.14 BiOracle Ltd (Inactive) Company Overview 39

5.15 Biosensia Ltd Company Overview 40

5.16 Biostealth, Inc. Company Overview 41

5.17 Biosurfit, SA Company Overview 42

5.18 Carclo Diagnostic Solutions Ltd Company Overview 43

5.19 CardioGenics Inc Company Overview 44

5.20 Cordex Systems, LLC Company Overview 45

5.21 Critical Diagnostics Company Overview 46

5.22 Diazyme Laboratories Inc Company Overview 47

5.23 Duke University Company Overview 48

5.24 Dynasil Corporation of America Company Overview 49

5.25 Edan Instruments Inc Company Overview 50

5.26 Epinex Diagnostics Inc Company Overview 52

5.27 ET Healthcare, Inc. Company Overview 53

5.28 General Biologicals Corp Company Overview 56

5.29 Group K Diagnostics Company Overview 57

5.30 LeukoDx Ltd Company Overview 60

5.31 MML Ltd Company Overview 61

5.32 Nanomix Inc Company Overview 63

5.33 Novartis AG Company Overview 64

5.34 Ohmx Corp Company Overview 65

5.35 OPKO Health Inc Company Overview 69

5.36 Prolight Diagnostics AB Company Overview 71

5.37 QLIDA Diagnostics Company Overview 72

5.38 QuickCheck Health Inc Company Overview 73

5.39 Radiometer Medical ApS Company Overview 74

5.40 Radisens Diagnostics Ltd Company Overview 75

5.41 Resdin Technologies Inc. Company Overview 76

5.42 Sandia National Laboratories Company Overview 77

5.43 Sarissa-Biomedical Ltd Company Overview 80

5.44 Selfa, Inc. Company Overview 81

5.45 SpinChip Diagnostics AS Company Overview 82

5.46 Thermo Fisher Scientific Inc Company Overview 83

5.47 ThreeFold Sensors (Inactive) Company Overview 84

5.48 Trinity Biotech Plc Company Overview 85

5.49 True Diagnostics Inc Company Overview 88

5.50 Universal Biosensors Inc Company Overview 89

5.51 Upstream Medical Technologies Ltd Company Overview 90

5.52 XCellCure, LLC Company Overview 99

6 Cardiac Markers Rapid Tests & Point of Care (POC)-Recent Developments 102

6.1 May 14, 2018: Dynasil Corporation Of America Reports Second Quarter Fiscal 2018 Net Income Of USD1.3 Million 102

6.2 May 01, 2018: Trinity Biotech announces Results for Q1, 2018 102

6.3 Apr 19, 2018: biomerieux-First-quarter 2018 Business Review 103

6.4 Mar 07, 2018: Trinity Biotech announces Quarter 4 and Fiscal Year 2017 Financial Results 105

6.5 Dec 20, 2017: Dynasil Corporation of America Reports Fiscal Year 2017 Financial Results 108

6.6 Nov 27, 2017: Beckman Coulter Enters Commercial Dispute with Quidde to Sell BNP Directly 108

6.7 Oct 26, 2017: Trinity Biotech Announces Results for Q3, 2017 109

6.8 Oct 18, 2017: bioMerieux-Business review for the nine months ended September 30, 2017 110

6.9 Sep 29, 2017: Alee Announces the U.S. Department of Justice Closes Investigation 112

6.10 Sep 28, 2017: Alee Announces Settlement with SEC 112

6.11 Aug 30, 2017: bioMerieux-First-Half 2017 Results 113

6.12 Aug 03, 2017: Alere Reports Second Quarter 2017 Financial Results 116

6.13 Jul 31, 2017: Sarissa And Aston University Receive A 2yr KTP Award To Develop An Automated SMARTChip Production Line. 117

6.14 Jul 20, 2017: bioMerieux-Second-Quarter 2017 Business Review 117

6.15 Jul 20, 2017: Trinity Biotech Announces Results for Q2, 2017 119

7 Appendix 122

7.1 Methodology 122

7.2 About GlobalData 125

7.3 Contact Us 125

7.4 Disclaimer 125

1.2 List of Figures

Figure 1: Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Stage of Development 11

Figure 2: Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Segment 12

Figure 3: Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Territory 13

Figure 4: Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Regulatory Path 14

Figure 5: Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Estimated Approval Date 15

1.1 List of Tables

Table 1: Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Stage of Development 11

Table 2: Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Segment 12

Table 3: Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Territory 13

Table 4: Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Regulatory Path 14

Table 5: Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Estimated Approval Date 15

Table 6: Cardiac Markers Rapid Tests & POC Companies-Pipeline Products by Stage of Development 16

Table 7: Cardiac Markers Rapid Tests & Point of Care (POC)-Pipeline Products by Stage of Development 19

Table 8: 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 22

Table 9: One Drop Diagnostic Device-Cardiovascular Disease-Product Status 22

Table 10: One Drop Diagnostic Device-Cardiovascular Disease-Product Description 22

Table 11: Abionic SA Pipeline Products & Ongoing Clinical Trials Overview 23

Table 12: IVD CAPSULE-Thrombose Test-Product Status 23

Table 13: IVD CAPSULE-Thrombose Test-Product Description 23

Table 14: Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 24

Table 15: pScreen BNP-Product Status 24

Table 16: pScreen BNP-Product Description 24

Table 17: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 25

Table 18: Diagnostic Test-Heart Attack-Product Status 25

Table 19: Diagnostic Test-Heart Attack-Product Description 25

Table 20: Akrivis Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 26

Table 21: Z-TECT-cTnI Assay-Product Status 26

Table 22: Z-TECT-cTnI Assay-Product Description 26

Table 23: Alfa Wassermann Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Table 24: ACE Alera Clinical Chemistry System-hsCRP Assay-Product Status 27

Table 25: ACE Alera Clinical Chemistry System-hsCRP Assay-Product Description 27

Table 26: ACE Axcel Clinical Chemistry System-hsCRP Assay-Product Status 28

Table 27: ACE Axcel Clinical Chemistry System-hsCRP Assay-Product Description 28

Table 28: Anteo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

Table 29: AtomoRapid-Heart Attack-Product Status 29

Table 30: AtomoRapid-Heart Attack-Product Description 29

Table 31: Point-Of-Care Troponin Test-Product Status 30

Table 32: Point-Of-Care Troponin Test-Product Description 30

Table 33: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview 31

Table 34: Premium Trace-B-type Natriuretic Peptide Assay-Product Status 31

Table 35: Premium Trace-B-type Natriuretic Peptide Assay-Product Description 31

Table 36: Trace-D-dimer Test-Product Status 32

Table 37: Trace-D-dimer Test-Product Description 32

Table 38: Axela Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Table 39: Cardiac Troponin Biomarker Kit-Product Status 33

Table 40: Cardiac Troponin Biomarker Kit-Product Description 33

Table 41: Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

Table 42: Afinion hsCRP Assay-Product Status 34

Table 43: Afinion hsCRP Assay-Product Description 34

Table 44: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Table 45: Mobile RDT Reader-Troponin-I Test-Product Status 35

Table 46: Mobile RDT Reader-Troponin-I Test-Product Description 35

Table 47: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 36

Table 48: Digital Strip Reader-Cardiac Marker-Product Status 36

Table 49: Digital Strip Reader-Cardiac Marker-Product Description 36

Table 50: Magnetic Immunoassay Detection System-Cardiac Myoglobin-Product Status 37

Table 51: Magnetic Immunoassay Detection System-Cardiac Myoglobin-Product Description 37

Table 52: Magnetic Immunoassay Detection System-Cardiac Troponin-Product Status 37

Table 53: Magnetic Immunoassay Detection System-Cardiac Troponin-Product Description 38

Table 54: Magnetic Immunoassay Detection System-CK MB-Product Status 38

Table 55: Magnetic Immunoassay Detection System-CK MB-Product Description 38

Table 56: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Table 57: Point of Care Test-Troponin-Product Status 39

Table 58: Point of Care Test-Troponin-Product Description 39

Table 59: BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40

Table 60: biO1042 Test-Product Status 40

Table 61: biO1042 Test-Product Description 40

Table 62: Biosensia Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

Table 63: RapiPlex-Myoglobin Assay-Product Status 41

Table 64: RapiPlex-Myoglobin Assay-Product Description 41

Table 65: Biostealth, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42

Table 66: Point-Of-Care Assay-B-Type Natriuretic Peptide-Product Status 42

Table 67: Point-Of-Care Assay-B-Type Natriuretic Peptide-Product Description 42

Table 68: Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview 43

Table 69: Spinit-D-dimer Test-Product Status 43

Table 70: Spinit-D-dimer Test-Product Description 43

Table 71: Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

Table 72: Micropoc-pro-Troponin-I Assay-Product Status 44

Table 73: Micropoc-pro-Troponin-I Assay-Product Description 44

Table 74: CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Table 75: Heart Failure Risk Stratification Test-Product Status 45

Table 76: Heart Failure Risk Stratification Test-Product Description 45

Table 77: Cordex Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 46

Table 78: SmartCuff-Product Status 46

Table 79: SmartCuff-Product Description 46

Table 80: Critical Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 47

Table 81: Aspect-PLUS ST2 Test-Product Status 47

Table 82: Aspect-PLUS ST2 Test-Product Description 47

Table 83: Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Table 84: ProADM Point-of-Care-Product Status 48

Table 85: ProADM Point-of-Care-Product Description 48

Table 86: Duke University Pipeline Products & Ongoing Clinical Trials Overview 49

Table 87: Multianalyte 2-D Diffusion Point-Of-Care Assay-Cardiac Infarction-Product Status 49

Table 88: Multianalyte 2-D Diffusion Point-Of-Care Assay-Cardiac Infarction-Product Description 49

Table 89: Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview 50

Table 90: Diagnostic Test-Cardiovascular Risk-Product Status 50

Table 91: Diagnostic Test-Cardiovascular Risk-Product Description 50

Table 92: Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview 51

Table 93: m16-CRP Assay-Product Status 51

Table 94: m16-CRP Assay-Product Description 51

Table 95: m16-D-dimer Assay-Product Status 52

Table 96: m16-D-dimer Assay-Product Description 52

Table 97: Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 53

Table 98: Epinex G1A-Coronary Artery Disease Rapid Diagnostic Test-Product Status 53

Table 99: Epinex G1A-Coronary Artery Disease Rapid Diagnostic Test-Product Description 53

Table 100: ET Healthcare, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54

Table 101: Pylon Assay-High-sensitivity C-reactive Protein-Product Status 54

Table 102: Pylon Assay-High-sensitivity C-reactive Protein-Product Description 54

Table 103: Pylon Assay-High-sensitivity Troponin I-Product Status 55

Table 104: Pylon Assay-High-sensitivity Troponin I-Product Description 55

Table 105: Pylon Assay-NT-ProBNP-Product Status 55

Table 106: Pylon Assay-NT-ProBNP-Product Description 56

Table 107: General Biologicals Corp Pipeline Products & Ongoing Clinical Trials Overview 57

Table 108: Point-Of-Care Diagnostic Assay-Troponin-I-Product Status 57

Table 109: Point-Of-Care Diagnostic Assay-Troponin-I-Product Description 57

Table 110: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 58

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

1Drop Diagnostics

Abionic SA

Accel Diagnostics LLC

Akers Biosciences Inc

Akrivis Technologies LLC

Alfa Wassermann Inc

Anteo Diagnostics Ltd

Atonomics A/S

Axela Inc

Axis-Shield Diagnostics Ltd

BBB Technologies Inc

Bio-Alternative Medical Devices Ltd

BioMedomics Inc

BiOracle Ltd

Biosensia Ltd

Biostealth, Inc.

Biosurfit, SA

Carclo Diagnostic Solutions Ltd

CardioGenics Inc

Cordex Systems, LLC

Critical Diagnostics

Diazyme Laboratories Inc

Duke University

Dynasil Corporation of America

Edan Instruments Inc

Epinex Diagnostics Inc

ET Healthcare, Inc.

General Biologicals Corp

Group K Diagnostics

LeukoDx Ltd

MML Ltd

Nanomix Inc

Novartis AG

Ohmx Corp

OPKO Health Inc

Prolight Diagnostics AB

QLIDA Diagnostics

QuickCheck Health Inc

Radiometer Medical ApS

Radisens Diagnostics Ltd

Resdin Technologies Inc.

Sandia National Laboratories

Sarissa-Biomedical Ltd

Selfa, Inc.

SpinChip Diagnostics AS

Thermo Fisher Scientific Inc

ThreeFold Sensors

Trinity Biotech Plc

True Diagnostics Inc

Universal Biosensors Inc

Upstream Medical Technologies Ltd

XCellCure, LLC

1Drop Diagnostics, One Drop Diagnostic Device - Cardiovascular Disease; Abionic SA, IVD CAPSULE - Thrombose Test; Accel Diagnostics LLC, pScreen BNP; Akers Biosciences Inc, Diagnostic Test - Heart Attack; Akrivis Technologies LLC, Z-TECT - cTnI Assay; Alfa Wassermann Inc, ACE Alera Clinical Chemistry System - hsCRP Assay; Alfa Wassermann Inc, ACE Axcel Clinical Chemistry System - hsCRP Assay; Anteo Diagnostics Ltd, AtomoRapid - Heart Attack; Anteo Diagnostics Ltd, Point-Of-Care Troponin Test; Atonomics A/S, Premium Trace - B-type Natriuretic Peptide Assay; Atonomics A/S, Trace - D-dimer Test; Axela Inc, Cardiac Troponin Biomarker Kit; Axis-Shield Diagnostics Ltd, Afinion hsCRP Assay; BBB Technologies Inc, Mobile RDT Reader - Troponin-I Test; Bio-Alternative Medical Devices Ltd, Digital Strip Reader - Cardiac Marker; Bio-Alternative Medical Devices Ltd, Magnetic Immunoassay Detection System - Cardiac Myoglobin; Bio-Alternative Medical Devices Ltd, Magnetic Immunoassay Detection System - Cardiac Troponin; Bio-Alternative Medical Devices Ltd, Magnetic Immunoassay Detection System - CK MB; BioMedomics Inc, Point of Care Test - Troponin; BiOracle Ltd (Inactive), biO1042 Test; Biosensia Ltd, RapiPlex - Myoglobin Assay; Biostealth, Inc., Point-Of-Care Assay - B-Type Natriuretic Peptide; Biosurfit, SA, Spinit - D-dimer Test; Carclo Diagnostic Solutions Ltd, Micropoc-pro - Troponin-I Assay; CardioGenics Inc, Heart Failure Risk Stratification Test; Cordex Systems, LLC, SmartCuff; Critical Diagnostics, Aspect - PLUS ST2 Test; Diazyme Laboratories Inc, ProADM Point-of-Care; Duke University, Multianalyte 2-D Diffusion Point-Of-Care Assay - Cardiac Infarction; Dynasil Corporation of America, Diagnostic Test - Cardiovascular Risk; Edan Instruments Inc, m16 - CRP Assay; Edan Instruments Inc, m16 - D-dimer Assay; Epinex Diagnostics Inc, Epinex G1A - Coronary Artery Disease Rapid Diagnostic Test; ET Healthcare, Inc., Pylon Assay - High-sensitivity C-reactive Protein; ET Healthcare, Inc., Pylon Assay - High-sensitivity Troponin I; ET Healthcare, Inc., Pylon Assay - NT-ProBNP; General Biologicals Corp, Point-Of-Care Diagnostic Assay - Troponin-I; Group K Diagnostics, Multidiagnostic - BNP Test; Group K Diagnostics, Multidiagnostic - Cardiac Function Test; Group K Diagnostics, Multidiagnostic - Troponin T And I Test; LeukoDx Ltd, Accellix Disposable Cartridges Test - Heart Disease; MML Ltd, MIDS Cardiac - Three Panel Test; MML Ltd, MIDS Cardiac - Troponin Test; Nanomix Inc, Omega-3 Cardiac Panel; Novartis AG, Diagnostic Test - Cardiac Panel; Ohmx Corp, Diagnostic Assay - hs Troponin I; Ohmx Corp, Diagnostic Test - hsCRP; Ohmx Corp, Portable POC System - BNP; Ohmx Corp, Portable POC System - CRP; Ohmx Corp, Portable POC System - hs Troponin I; OPKO Health Inc, Claros 1 - Cardiovascular Diseases; OPKO Health Inc, Diagnostic Assay - CTnl; Prolight Diagnostics AB, High-Sensitivity Troponin Test; QLIDA Diagnostics, QLIDA - Cardiovascular Disease; QuickCheck Health Inc, Diagnostic Test - Cholesterol; Radiometer Medical ApS, AQT90 FLEX - BNP Test; Radisens Diagnostics Ltd, Gemini - Cardiovascular Disease Panel; Resdin Technologies Inc., Quick At-Home Diagnostic Test - Myocardial Infarction; Sandia National Laboratories, RapiDx Assay - BNP; Sandia National Laboratories, RapiDx Assay - CK-MB; Sandia National Laboratories, RapiDx Assay - CRP; Sandia National Laboratories, RapiDx Assay - cTN; Sarissa-Biomedical Ltd, SMARTChip; Selfa, Inc., Point-Of-Care Assay - Acute Myocardial Infarction; SpinChip Diagnostics AS, cTnl Assay; Thermo Fisher Scientific Inc, Point-Of-Care Platform - Cardiac Disorders Assay; ThreeFold Sensors (Inactive), Diagnostic Test - Heart Attack; Trinity Biotech Plc, D-dimer Test; Trinity Biotech Plc, Meritas Troponin I Test; Trinity Biotech Plc, Multiplex Cardiac Panel; True Diagnostics Inc, TrueDX - Cardiac Health Test; Universal Biosensors Inc, Immunoassay Test - D-Dimer; Upstream Medical Technologies Ltd, CNP-sp Test - Heart Disease; Upstream Medical Technologies Ltd, CRP Assay - Heart Failure; Upstream Medical Technologies Ltd, EPO-sp Test; Upstream Medical Technologies Ltd, GH Assay - Heart Failure; Upstream Medical Technologies Ltd, Ghr-sp Test - Heart Disease; Upstream Medical Technologies Ltd, Ghr-sp-Pne Test - Heart Failure; Upstream Medical Technologies Ltd, IGFs Assay - Heart Failure; Upstream Medical Technologies Ltd, INS-sp Test - Heart failure; Upstream Medical Technologies Ltd, KIM1 Assay - Heart failure; Upstream Medical Technologies Ltd, NGAL-sp Test - Heart Failure; Upstream Medical Technologies Ltd, PSA Assay - Heart Failure; Upstream Medical Technologies Ltd, TSH Assay - Heart Failure; XCellCure, LLC, AMiAware Human Cardiovascular Disease Microarray; XCellCure, LLC, AMiAware Rapid Cardiac Provider Panel Assay; XCellCure, LLC, AMiAware Rapid Patient Point Of Care Cardiac Panel

select a license
Single User License
USD 4000 INR 285320
Site License
USD 8000 INR 570640
Corporate User License
USD 12000 INR 855960

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com